Particle Therapy Market Size is Expected to Reach USD 3.50 Billion by 2035 Caused by the Increasing Prevalence of Cancer Cases Globally | SNS Insider

U.S. Particle Therapy Market is predicted to increase from 0.52 billion in 2025 to 1.04 billion by 2035 due to increasing cancer cases in the country

Austin, March 25, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Particle Therapy Market size is valued at USD 1.61 Billion in 2025 and is expected to reach USD 3.50 Billion by 2035, growing at a CAGR of 8.20% during 2026–2035.

The main factors driving the particle therapy market’s growth are the rising incidence of cancer cases, the growing acceptance of heavy ion and proton therapy, the growing acceptance of precision medicine in cancer treatment, and the quick development of healthcare infrastructure.

Particle Therapy Market Size and Forecast:

• Market Size in 2025: USD 1.61 Billion
• Market Size by 2035: USD 3.50 Billion
• CAGR: 8.20% from 2026 to 2035
• Base Year: 2025
• Forecast Period: 2026–2035
• Historical Data: 2022–2024

Get Exclusive Access to the Sample Report of Particle Therapy Market Forecast @ https://www.snsinsider.com/sample-request/9867

The Particle Therapy Market is predicted to increase from 0.52 billion in 2025 to 1.04 billion by 2035 at a steady CAGR of 7.92%.

The growth can be attributed to a rise in global cancer cases, a rise in the use of proton and heavy ion therapy, and a widening range of applications in paediatric cancer, head & neck cancer, and lung cancer. 

Rising Global Cancer Incidence and Increasing Demand for Precision Oncology to Drive Market Growth Globally

Hospitals, specialty oncology centers, and research institutions worldwide are increasingly using state-of-the-art proton and heavy ion therapy systems for better treatment outcomes and minimizing side effects, especially for paediatric and head & neck cancer treatments. Increased availability of single-room, compact, and modular systems is making it easier for more institutions and researchers to access and use particle therapy, and recent advances in beam delivery, imaging integration, and artificial intelligence-based treatment planning techniques are making it more patient-compliant.

Particle Therapy Market Segmentation Analysis:

By Therapy Type

Proton Therapy held the largest market share of 86.46% in 2025 owing to proven clinical efficacy, lower side effects, and wide reimbursement coverage in North America and Europe. Heavy ION Therapy are expected to grow at the fastest CAGR of 10.87% during 2026–2035 driven by its high biological effectiveness in treating radio-resistant tumours such as sarcomas, pancreatic cancer, and recurrent head and neck tumours.

By System Type

Multi-room System dominated with 66.55% market share in 2025 due to its capability to treat patients simultaneously in multiple gantries. Compact Proton Systems are projected to record the fastest CAGR of 9.77% through 2026–2035 due to advancements in single-room designs, reduced requirements for shielding, and shorter installation schedules.

By Application

Treatment accounted for the highest market share of 92.12% in 2025 due to the gold-standard status of particle therapy in treating complex cancers where accuracy is a prime concern. Clinical Research are expected to grow at the fastest CAGR of 9.11% during the forecast period due to advancements in translational oncology and investigations into particle therapy in combination with immunotherapy agents and biologics.

By Cancer Type

Paediatric cancer dominated with a 22.27% share in 2025 driven by its unparalleled capability to minimize side effects in paediatric and young patients. Head & Neck Cancer are anticipated to expand at the fastest CAGR of 7.79% through 2026–2035 driven by its precision in treating tumours in areas close to critical structures such as the brainstem, spinal cord, and optic nerves.

For an In-Depth Strategic Briefing with Our Research Team, Connect Now @ https://www.snsinsider.com/request-analyst/9867

Particle Therapy Market Regional Insights:

Due to the high incidence of cancer and the robust infrastructure in the U.S. and Canada, the North American particle therapy market has been dominated, with a share of 42.44% in 2025. Due to favorable payment rules and a high degree of expertise, proton therapy systems have been widely accepted in hospitals and specialist clinics, which has significantly accelerated expansion in North America.

Asia-Pacific is the fastest-growing region for the Asia-Pacific Particle Therapy Market, with 10.75% CAGR in 2025. The region is witnessing a rise in cancer cases, development of healthcare infrastructure, and robust investments by governments. 

Major Players Analysis Listed in the Particle Therapy Market Report:

• Ion Beam Applications (IBA)
• Varian Medical Systems (Siemens Healthineers)
• Hitachi Ltd.
• Mitsubishi Electric Corporation
• Sumitomo Heavy Industries Ltd.
• Mevion Medical Systems Inc.
• ProTom International Inc.
• Advanced Oncotherapy Plc
• Optivus Proton Therapy Inc.
• Elekta AB
• Toshiba Energy Systems & Solutions Corporation
• ACCEL Instruments GmbH
• Shinva Medical Instrument Co. Ltd.
• Particle Therapy Co. Ltd. (Japan)
• Panacea Medical Technologies Pvt. Ltd.
• HBL Power Systems Ltd.
• Fermilab (Collaborative Technology)
• Varian Particle Therapy GmbH
• Sumitomo Dainippon Pharma Oncology
• Proton International Inc.

Particle Therapy Market Recent Developments:

• In September 2025, IBA announced successful commissioning of a new compact proton therapy system in India, expanding accessibility and reinforcing its leadership in emerging markets.
• In October 2025, Varian launched its next-generation proton therapy platform featuring enhanced imaging integration, aiming to improve treatment precision and patient outcomes.

Purchase Comprehensive Particle Therapy Market Report – Single User PDF @ https://www.snsinsider.com/checkout/9867

Exclusive Sections of the Report (The USPs):

• ADOPTION & USAGE METRICS – helps you understand penetration of proton and heavy ion therapy across cancer centers, patient treatment volumes, and adoption trends across system types and oncology segments.
• OPERATIONAL & PERFORMANCE METRICS – helps you evaluate treatment efficiency, beam precision, machine reliability, and accuracy in dose delivery for improved clinical outcomes.
• TECHNOLOGY & INNOVATION METRICS – helps you track advancements such as AI-driven treatment planning, compact system adoption, and innovations enhancing patient safety and precision.
• END-USE & MARKET INSIGHTS – helps you identify regional adoption trends, end-user preferences, and the impact of evolving oncology practices on demand for particle therapy systems.
• CLINICAL OUTCOME & DEMAND DRIVERS – helps you assess improvements in survival rates, growing demand from paediatric oncology, and increased usage in rare and complex cancer treatments.

Particle Therapy Market Report Scope:

Rising Demand for Particle Therapy Market Data, Our Full Report Trend Analysis @ https://www.snsinsider.com/reports/particle-therapy-market-9867

Other Related Report:

Radiation Oncology Treatment Planning Software Market

Radiotherapy Market

Skin Cancer Treatment Market

Genomics In Cancer Care Market

Medical Radiation Shielding Market

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. DailyIndiaNews.com takes no editorial responsibility for the same.